The DOI matches its Crossref record; 37 of the 37 references it cites were found in a registry or an index.
Changes in Cardiac Biomarkers During Doxorubicin Treatment of Pediatric Patients With High-Risk Acute Lymphoblastic Leukemia: Associations With Long-Term Echocardiographic Outcomes
Open accessAbstract
Purpose: Doxorubicin causes cardiac injury and cardiomyopathy in children with acute lymphoblastic leukemia (ALL). Measuring biomarkers during therapy might help individualize treatment by immediately identifying cardiac injury and cardiomyopathy. Patients and Methods: Children with high-risk ALL were randomly assigned to receive doxorubicin alone (n = 100; 75 analyzed) or doxorubicin with dexrazoxane (n = 105; 81 analyzed). Echocardiograms and serial serum measurements of cardiac troponin T (cTnT; cardiac injury biomarker), N-terminal pro-brain natriuretic peptide (NT-proBNP; cardiomyopathy biomarker), and high-sensitivity C-reactive protein (hsCRP; inflammatory biomarker) were obtained before, during, and after treatment. Results: cTnT levels were increased in 12% of children in the doxorubicin group and in 13% of the doxorubicin-dexrazoxane group before treatment but in 47% and 13%, respectively, after treatment (P = .005). NT-proBNP levels were increased in 89% of children in the doxorubicin group and in 92% of children in the doxorubicin-dexrazoxane group before treatment but in only 48% and 20%, respectively, after treatment (P = .07). The percentage of children with increased hsCRP levels did not differ between groups at any time. In the first 90 days of treatment, detectable increases in cTnT were associated with abnormally reduced left ventricular (LV) mass and LV end-diastolic posterior wall thickness 4 years later (P < .01); increases in NT-proBNP were related to an abnormal LV thickness-to-dimension ratio, suggesting LV remodeling, 4 years later (P = .01). Increases in hsCRP were not associated with any echocardiographic variables. Conclusion: cTnT and NT-proBNP may hold promise as biomarkers of cardiotoxicity in children with high-risk ALL. Definitive validation studies are required to fully establish their range of clinical utility.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Jemal, A., Siegel, R., Ward, E., Hao, Y., Xu, J., Murray, T., & Thun, M. J. (2008) · CA: A Cancer Journal for Clinicians · doi:10.3322/ca.2007.0010 · Cited by 10,188
Black, S., Kushner, I., & Samols, D. (2004) · Journal of Biological Chemistry · doi:10.1074/jbc.r400025200 · Cited by 1,844
Plasma Natriuretic Peptide Levels and the Risk of Cardiovascular Events and Death
Wang, T. J., Larson, M. G., Levy, D., Benjamin, E. J., Leip, E. P., Omland, T., Wolf, P. A., & Vasan, R. S. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa031994 · Cited by 1,527
Braunwald, E. (2008) · New England Journal of Medicine · doi:10.1056/nejmra0800239 · Cited by 1,257
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · Circulation · doi:10.1161/circulationaha.107.186093 · Cited by 1,030
Cardinale, D., Sandri, M. T., Colombo, A., Colombo, N., Boeri, M., Lamantia, G., Civelli, M., Peccatori, F., Martinelli, G., Fiorentini, C., et al. (2004) · Circulation · doi:10.1161/01.cir.0000130926.51766.cc · Cited by 955
Use of Multiple Biomarkers to Improve the Prediction of Death from Cardiovascular Causes
Zethelius, B., Berglund, L., Sundström, J., Ingelsson, E., Basu, S., Larsson, A., Venge, P., & Ärnlöv, J. (2008) · New England Journal of Medicine · doi:10.1056/nejmoa0707064 · Cited by 889
Lipshultz, S. E., Lipsitz, S. R., Mone, S. M., Goorin, A. M., Sallan, S. E., Sanders, S. P., Orav, E. J., Gelber, R. D., & Colan, S. D. (1995) · New England Journal of Medicine · doi:10.1056/nejm199506293322602 · Cited by 803
Self-citationThe Role of Endomyocardial Biopsy in the Management of Cardiovascular Disease
Cooper, L. T., Baughman, K. L., Feldman, A. M., Frustaci, A., Jessup, M., Kuhl, U., Levine, G. N., Narula, J., Starling, R. C., Towbin, J., et al. (2007) · Journal of the American College of Cardiology · doi:10.1016/j.jacc.2007.09.008 · Cited by 672
Clyne, B., & Olshaker, J. S. (1999) · The Journal of Emergency Medicine · doi:10.1016/s0736-4679(99)00135-3 · Cited by 668
It’s Time for a Change to a Troponin Standard
Jaffe, A. S., Ravkilde, J., Roberts, R., Naslund, U., Apple, F. S., Galvani, M., & Katus, H. (2000) · Circulation · doi:10.1161/01.cir.102.11.1216 · Cited by 643
N-Terminal Pro–B-Type Natriuretic Peptide and Long-Term Mortality in Stable Coronary Heart Disease
Kragelund, C., Grønning, B., Køber, L., Hildebrandt, P., & Steffensen, R. (2005) · New England Journal of Medicine · doi:10.1056/nejmoa042330 · Cited by 631
Lipshultz, S. E., Rifai, N., Dalton, V. M., Levy, D. E., Silverman, L. B., Lipsitz, S. R., Colan, S. D., Asselin, B. L., Barr, R. D., Clavell, L. A., et al. (2004) · New England Journal of Medicine · doi:10.1056/nejmoa035153 · Cited by 623
Self-citationN-Terminal Pro-B–Type Natriuretic Peptide and Long-Term Mortality in Acute Coronary Syndromes
Omland, T., Persson, A., Ng, L., O’Brien, R., Karlsson, T., Herlitz, J., Hartford, M., & Caidahl, K. (2002) · Circulation · doi:10.1161/01.cir.0000041661.63285.ae · Cited by 576
Left ventricular dysfunction predicted by early troponin I release after high-dose chemotherapy
Cardinale, D., Sandri, M. T., Martinoni, A., Tricca LabTech, A., Civelli, M., Lamantia, G., Cinieri, S., Martinelli, G., Cipolla, C. M., & Fiorentini, C. (2000) · Journal of the American College of Cardiology · doi:10.1016/s0735-1097(00)00748-8 · Cited by 551
Theoretical and empirical derivation of cardiovascular allometric relationships in children
Sluysmans, T., & Colan, S. D. (2005) · Journal of Applied Physiology · doi:10.1152/japplphysiol.01144.2004 · Cited by 514
Self-citationAnthracycline Cardiotoxicity: From Bench to Bedside
Gianni, L., Herman, E. H., Lipshultz, S. E., Minotti, G., Sarvazyan, N., & Sawyer, D. B. (2008) · Journal of Clinical Oncology · doi:10.1200/jco.2007.14.9401 · Cited by 454
Self-citationLipshultz, S. E., Scully, R. E., Lipsitz, S. R., Sallan, S. E., Silverman, L. B., Miller, T. L., Barry, E. V., Asselin, B. L., Athale, U., Clavell, L. A., et al. (2010) · The Lancet Oncology · doi:10.1016/s1470-2045(10)70204-7 · Cited by 446
Self-citationMoghrabi, A., Levy, D. E., Asselin, B., Barr, R., Clavell, L., Hurwitz, C., Samson, Y., Schorin, M., Dalton, V. K., Lipshultz, S. E., et al. (2007) · Blood · doi:10.1182/blood-2006-06-027714 · Cited by 403
Self-citationPredictive Value of Cardiac Troponin T in Pediatric Patients at Risk for Myocardial Injury
Lipshultz, S. E., Rifai, N., Sallan, S. E., Lipsitz, S. R., Dalton, V., Sacks, D. B., & Ottlinger, M. E. (1997) · Circulation · doi:10.1161/01.cir.96.8.2641 · Cited by 384
Self-citationAnthracycline associated cardiotoxicity in survivors of childhood cancer
Lipshultz, S. E., Alvarez, J. A., & Scully, R. E. (2008) · Heart · doi:10.1136/hrt.2007.136093 · Cited by 379
Self-citationAnthracycline-induced cardiotoxicity: course, pathophysiology, prevention and management
Barry, E., Alvarez, J. A., Scully, R. E., Miller, T. L., & Lipshultz, S. E. (2007) · Expert Opinion on Pharmacotherapy · doi:10.1517/14656566.8.8.1039 · Cited by 307
Self-citationUltrasensitive Flow-based Immunoassays Using Single-Molecule Counting
Todd, J., Freese, B., Lu, A., Held, D., Morey, J., Livingston, R., & Goix, P. (2007) · Clinical Chemistry · doi:10.1373/clinchem.2007.091181 · Cited by 289
Bibbins-Domingo, K., Gupta, R., Na, B., Wu, A. H. B., Schiller, N. B., & Whooley, M. A. (2007) · JAMA · doi:10.1001/jama.297.2.169 · Cited by 276
Biology of the Natriuretic Peptides
Martinez-Rumayor, A., Richards, A. M., Burnett, J. C., & Januzzi, J. L. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.012 · Cited by 235
The Amino-Terminal Portion of Pro-Brain Natriuretic Peptide (Pro-BNP) Circulates in Human Plasma
Hunt, P. J., Yandle, T. G., Nicholls, M. G., Richards, A. M., & Espiner, E. A. (1995) · Biochemical and Biophysical Research Communications · doi:10.1006/bbrc.1995.2410 · Cited by 230
The connection between C‐reactive protein and atherosclerosis
Singh, S. K., Suresh, M. V., Voleti, B., & Agrawal, A. C. (2008) · Annals of Medicine · doi:10.1080/07853890701749225 · Cited by 158
Review of Tests for Monitoring Doxorubicin-lnduced Cardiomyopathy
Ganz, W. I., Sridhar, K. S., Ganz, S. S., Gonzalez, R. R., Chakko, S. C., & Serafini, A. N. (2009) · Oncology · doi:10.1159/000227621 · Cited by 151
Grewal, J., McKelvie, R. S., Persson, H., Tait, P., Carlsson, J., Swedberg, K. B., Östergren, J., & Lonn, E. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2008.04.048 · Cited by 107
Parameter Estimation in Longitudinal Studies with Outcome-Dependent Follow-Up
Lipsitz, S. R., Fitzmaurice, G. M., Ibrahim, J. G., Gelber, R. D., & Lipshultz, S. E. (2002) · Biometrics · doi:10.1111/j.0006-341x.2002.00621.x · Cited by 99
Self-citationVentricular dysfunction clinical research in infants, children and adolescents
Lipshultz, S. E. (2000) · Progress in Pediatric Cardiology · doi:10.1016/s1058-9813(00)00076-x · Cited by 79
Self-citationUsing C-reactive protein to assess cardiovascular disease risk.
Shishehbor, M. H., Bhatt, D. L., & Topol, E. J. (2003) · Cleveland Clinic Journal of Medicine · doi:10.3949/ccjm.70.7.634 · Cited by 70
Associations between neurohormonal and inflammatory activation and heart failure in children
Ratnasamy, C., Kinnamon, D. D., Lipshultz, S. E., & Rusconi, P. G. (2008) · American Heart Journal · doi:10.1016/j.ahj.2007.11.001 · Cited by 64
Self-citationLorgis, L., Zeller, M., Dentan, G., Sicard, P., Buffet, P., L’Huillier, I., Beer, J., Vincent-Martin, M., Makki, H., Gambert, P., et al. (2009) · BMJ · doi:10.1136/bmj.b1605 · Cited by 61
Amino-Terminal Pro–B-Type Natriuretic Peptides and Prognosis in Chronic Heart Failure
Masson, S., & Latini, R. (2008) · The American Journal of Cardiology · doi:10.1016/j.amjcard.2007.11.024 · Cited by 51
Krischer, J. P., Cuthbertson, D. D., Epstein, S., Goorin, A. M., Epstein, M. L., & Lipshultz, S. E. (1997) · Progress in Pediatric Cardiology · doi:10.1016/s1058-9813(98)00005-8 · Cited by 23
Self-citation
Cited by
Lyon, A. R., López-Fernández, T., Couch, L. S., Asteggiano, R., Aznar, M. C., Bergler-Klein, J., Boriani, G., Cardinale, D., Cordoba, R., Cosyns, B., et al. (2022) · European Heart Journal · doi:10.1093/eurheartj/ehac244 · Cited by 3,076
Early Detection of Anthracycline Cardiotoxicity and Improvement With Heart Failure Therapy
Cardinale, D., Colombo, A., Bacchiani, G., Tedeschi, I., Meroni, C. A., Veglia, F., Civelli, M., Lamantia, G., Colombo, N., Curigliano, G., et al. (2015) · Circulation · doi:10.1161/circulationaha.114.013777 · Cited by 1,733
Cardiotoxicity of anticancer treatments: Epidemiology, detection, and management
Curigliano, G., Cardinale, D., Dent, S., Criscitiello, C., Aseyev, O., Lenihan, D., & Cipolla, C. M. (2016) · CA: A Cancer Journal for Clinicians · doi:10.3322/caac.21341 · Cited by 723
Lipshultz, S. E., Adams, M. J., Colan, S. D., Constine, L. S., Herman, E. H., Hsu, D. T., Hudson, M. M., Kremer, L. C., Landy, D. C., Miller, T. L., et al. (2013) · Circulation · doi:10.1161/cir.0b013e3182a88099 · Cited by 612
Self-citationArmenian, S. H., Hudson, M. M., Mulder, R. L., Chen, M. H., Constine, L. S., Dwyer, M., Nathan, P. C., Tissing, W. J. E., Shankar, S., Sieswerda, E., et al. (2015) · The Lancet Oncology · doi:10.1016/s1470-2045(14)70409-7 · Cited by 570
Metadata
- Authors
- Lipshultz, S. E., Miller, T. L., Scully, R. E., Lipsitz, S. R., Rifai, N., Silverman, L. B., Colan, S. D., Neuberg, D. S., Dahlberg, S. E., Henkel, J. M., Asselin, B. L., Athale, U. H., Clavell, L. A., Laverdière, C., Michon, B., Schorin, M. A., & Sallan, S. E.
- Venue
- Journal of Clinical Oncology
- Published
- 2012-04-01
- Volume
- 30
- Issue
- 10
- Pages
- 1042-1049
- ISSN
- 0732-183X (ISSN-L)
- 1527-7755
- OpenAlex
- W2165287255
- Cited by
- 323
- References
- 37
- FWCI
- 18.22
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.